Horizon Kinetics Medical ETF Rating $37.08 -0.10 (-0.27%) As of 09/3/2026 03:50 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatings Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDX Aggregate RatingModerate Buy 2.68Holdings in MEDX have an aggregate rating of Moderate Buy based on 409 analyst ratings issued in the past year covering 22 companies (78.6% of the portfolio).MEDX Aggregate Price Target$37.08High Prediction$37.08Average Prediction$37.08Low Prediction$37.08Holdings in MEDX have an aggregate price target of $37.08 and a range of $37.08 to $37.08 covering 22 companies (78.6% of the portfolio).MEDX Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Horizon Kinetics Medical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 MEDX Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings18.60%LLYEli Lilly and Company$1,160.98+0.1%4.9262 of 5 stars2.83$1,292.18 11.3%30Trending NewsAnalyst Upgrade9.48%ABBVAbbVie$260.69-0.4%4.6091 of 5 stars2.88$275.95 5.9%26Trending News5.90%JNJJohnson & Johnson$278.66+1.3%4.5737 of 5 stars2.80$272.83 -2.1%25Trending NewsAnalyst ForecastAnalyst Revision5.53%ALKSAlkermes$46.88-1.8%2.2812 of 5 stars2.72$54.56 16.4%18Insider Trade5.21%BMYBristol Myers Squibb$68.06+0.6%4.7223 of 5 stars2.56$66.06 -2.9%25Trending NewsAnalyst Revision4.39%AMGNAmgen$444.12+0.3%4.1857 of 5 stars2.40$380.43 -14.3%30Positive NewsAnalyst Revision4.18%MRKMerck & Co., Inc.$152.32+0.4%4.5149 of 5 stars2.65$147.60 -3.1%23Positive NewsAnalyst Revision3.19%IONSIonis Pharmaceuticals$58.13-5.2%3.7346 of 5 stars2.73$94.15 62.0%22Positive NewsHigh Trading Volume3.11%BIIBBiogen$224.51+0.8%3.3889 of 5 stars2.58$228.50 1.8%33Trending NewsAnalyst Forecast3.10%PFEPfizer$28.82-0.7%3.8867 of 5 stars2.19$28.28 -1.9%21Trending NewsAnalyst UpgradeOptions VolumeAnalyst Revision2.81%GSKGSK$50.88+0.9%3.0782 of 5 stars2.10$53.00 4.2%10News CoverageDividend CutGap Up2.55%REGNRegeneron Pharmaceuticals$843.47-1.0%4.0657 of 5 stars2.58$800.36 -5.1%24Trending NewsInsider Trade2.45%CRSPCRISPR Therapeutics$56.49-0.8%2.4106 of 5 stars2.61$68.06 20.5%18News CoverageAnalyst Forecast2.44%ALNYAlnylam Pharmaceuticals$264.50-1.1%4.5956 of 5 stars2.88$386.14 46.0%25Positive NewsAnalyst Forecast1.22%BEAMBeam Therapeutics$29.46+0.6%2.258 of 5 stars2.69$49.00 66.3%13Positive News0.83%GALTGalectin Therapeutics$4.35-2.9%1.7271 of 5 stars2.00$11.00 152.9%30.77%NTLAIntellia Therapeutics$12.68-0.6%2.8388 of 5 stars2.35$21.15 66.8%23Positive News0.77%SDZNYSandoz Group$87.20+2.9%1.7508 of 5 stars3.605Positive NewsAnalyst RevisionGap Up0.68%HLNHaleon$9.83-0.8%3.6141 of 5 stars2.5511News CoveragePositive NewsHigh Trading Volume0.64%VNDAVanda Pharmaceuticals$5.34-3.4%2.5589 of 5 stars2.50$13.70 156.6%80.41%EDITEditas Medicine$3.082.2212 of 5 stars2.67$5.80 88.3%6Positive News0.37%REPLReplimune Group$15.29-4.3%2.066 of 5 stars2.60$12.00 -21.5%10 This page (NASDAQ:MEDX) was last updated on 9/4/2026 by MarketBeat.com Staff. From Our PartnersThe 2026 beginners Guide to Gold IRAsGold trades near record highs while silver just topped $81 an ounce for the first time ever. Thousands of A...Goldco Direct, LLC | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredBefore Anthropic becomes impossible to ignore...Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...The Oxford Club | SponsoredAre you leaving Social Security money on the table?Most retirement plans still have gaps in them... The quiet ones that don't show up until it's too late to fix....Money Pickle | SponsoredHow Long Does $2.5M Last in Retirement?Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredRickards Predicts: Trump to buy tiny $2 stock?Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...Paradigm Press | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Kinetics Medical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Kinetics Medical ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
